Colorectal Cancer

 

Cetuximab and/or Bevacizumab + Combination Chemotherapy For Metastatic Colorectal Cancer (CTSU C80405)
A Phase III Trial of Irinotecan(Camptosar)/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin With Bevacizumab (Avastin), or Cetuximab (C225) (Erbitux), or With The Combination of Bevacizumab, or Cetuximab For Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum

Investigator: Fred Appelbaum, MD;   Conditions: Colon Cancer, Rectal Cancer, Colorectal Cancer;    Status: Recruiting;   Study ID: NCT00265850

SIR-Sphere + FOLFOX for Liver Metastases from Colorectal Cancer (UW10025)
Randomised Comparative Study Of Folfox6m Plus SIR-Spheres® Microspheres Versus Folfox6m Alone As First Line Treatment In Patients With Nonresectable Liver Metastases From Primary Colorectal Carcinoma

Investigator: Samuel Whiting, MD, PhD;   Conditions: Colorectal Cancer, Colorectal Carcinoma, Liver Metastases;    Status: Recruiting;   Study ID: NCT00724503

A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-Operative Therapy of Rectal Cancer (SWOG 0713)
Oxaliplatin (Eloxatin), Capecitabine (Xeloda), Cetuximab, and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Investigator: Fred Appelbaum, MD;   Conditions: Colorectal Cancer;    Status: Recruiting;   Study ID: NCT00686166